Sales decline 37.41% to Rs 474.80 crore
Net profit of Natco Pharma declined 37.47% to Rs 133.00 crore in the quarter ended December 2024 as against Rs 212.70 crore during the previous quarter ended December 2023. Sales declined 37.41% to Rs 474.80 crore in the quarter ended December 2024 as against Rs 758.60 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales474.80758.60 -37 OPM %8.1735.34 -PBDT210.70300.50 -30 PBT163.70256.30 -36 NP133.00212.70 -37Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
